LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2017-2023)

  • ID: 4481637
  • Report
  • 85 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Alcon Inc. (Novartis)
  • Allergan Plc
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • InnFocus Inc.
  • iSTAR Medical
  • MORE
The LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is expected to witness market growth of 31.9% CAGR during the forecast period (2017 - 2023).
Minimally invasive glaucoma surgery (MIGS) devices are used to treat glaucoma to provide a safer and lesser invasive means of reducing intraocular pressure (IOP), as compared to conventional glaucoma surgery devices. MIGS devices is expected to be most preferred surgical modality during the forecast period to treat glaucoma. It limits the dependency on conventional medications as well as cuts the complications associated with traditional procedures. MIGS devices are used in combined cataract surgeries through phacoemulsification.
Growing cases of glaucoma on a global level, reoccurrence of glaucoma along with other disorders of the eyes, and growing demand for ab interno approach to treat glaucoma are the factors that contribute to the market growth. Glaucoma is mostly prevalent in the geriatric population, who suffer from mild to moderate glaucoma conditions, primary angle-closure glaucoma, and secondary angle-closure glaucoma. This is expected to be a factor that is expected to drive the growth of this market. Ineffective drug delivery has propelled the transition of glaucoma treatment, from medication to minimally invasive glaucoma surgery (MIGS) devices, and as a result, adding to the market growth. Additionally, growing investment in the emerging economies and initiatives taken to reduce the burden of glaucoma on a global level is expected to provide excellent market opportunities during the forecast period.

Based on Surgery, the market report segments the market into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. The market by target segment covers Trabecular Meshwork, Suprachoroidal Space, and Other Targets. Based on product, the market is segment into MIGS Stents, MIGS Shunts, and Other Products. The end User covered under the report is Eye Hospitals, Ophthalmology Clinics, and Outpatient Surgical Centers. The report also covers country wise segmentation of Minimally Invasive Glaucoma Surgery (MIGS) Devices market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market. Key companies profiled in the report include Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alcon Inc. (Novartis)
  • Allergan Plc
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • InnFocus Inc.
  • iSTAR Medical
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research

2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

3. LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.1 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
3.1.1 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Stand-Alone Glaucoma Market by Country
3.1.2 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Glaucoma in Conjunction with Cataract Market by Country

4. LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
4.1 Introduction
4.1.1 LAMEA Eye Hospitals Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
4.1.2 LAMEA Ophthalmology Clinics Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
4.1.3 LAMEA Outpatient Surgical Centers Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country

5. LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
5.1 Introduction
5.1.1 LAMEA Suprachoroidal Space Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
5.1.2 LAMEA Trabecular Meshwork Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
5.1.3 LAMEA Other Targets Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country

6. LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
6.1 Introduction
6.1.1 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices in MIGS Shunts Market by Country
6.1.2 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices in MIGS Stents Market by Country
6.1.3 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other Products Market by Country

7. LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
7.1 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.1.3 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.4 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2.3 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.4 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3.3 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.4 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4.3 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.4 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.5 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.5.1 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.5.2 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.5.3 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.5.4 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.6 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.6.1 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.6.2 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.6.3 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.6.4 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.7 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.7.1 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.7.2 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.7.3 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.7.4 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product

8. Company Profile
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development Expense
8.5 Alcon Inc. (Novartis)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Research & Development Expense
8.6 Lumenis
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Ivantis, Inc.
8.7.1 Company Overview
8.8 iSTAR Medical
8.8.1 Company Overview
8.9 InnFocus Inc.
8.9.1 Company Overview
8.1 SOLX, Inc
8.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ellex Medical Lasers Ltd.
  • Allergan Plc
  • Santen Pharmaceutical Co., Ltd.
  • Glaukos Corporation
  • Alcon Inc. (Novartis)
  • Lumenis
  • Ivantis, Inc.
  • iSTAR Medical
  • SOLX, Inc
  • InnFocus Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll